Ingestion of milk containing the Dp2 peptide, a dust mite allergen, protects mice from allergic airway inflammation and hyper-responsiveness

Allergy, Asthma and Clinical Immunology

Volumn 9, Issue 1, 2013, Pages

  Liu, Hsu Chung ^a,b   Pai, Shun Yuan ^a   Cheng, Winston T K ^c   Chen, Hsiao Ling ^d   Tsai, Tung Chou ^a   Yang, Shang Hsun ^e   Chen, Chuan Mu ^a  

^a NATIONAL CHUNG HSING UNIVERSITY   (Taiwan)

^b CHUNG SHAN MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c TUNGHAI UNIVERSITY   (Taiwan)

^d DA YEH UNIVERSITY   (Taiwan)

^e NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

Author keywords

Allergen; Asthma; Group 2 allergen of Dermatophagoides pteronyssinus; Immunotherapy; Tolerance; Transgenic mice

Indexed keywords

DP2 PEPTIDE; HOUSE DUST ALLERGEN; UNCLASSIFIED DRUG;

ALLERGIC AIRWAY INFLAMMATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DERMATOPHAGOIDES PTERONYSSINUS; DOWN REGULATION; IMMUNOHISTOCHEMISTRY; LUNG ALVEOLUS; LUNG FUNCTION; LUNG LAVAGE; MILK; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; RESPIRATORY TRACT ALLERGY; SENSITIZATION; TH1 CELL; TH2 CELL;

EID: 84879443533     PISSN: 17101484     EISSN: 17101492     Source Type: Journal    
DOI: 10.1186/1710-1492-9-21     Document Type: Article

References (38)

1. Sporik R, Chapman MD, Platts-Mills TA. House dust mite exposure as a cause of asthma. Clin Exp Allergy 1992, 22:897-906. 10.1111/j.1365-2222.1992.tb02062.x, 1464045.
2. Thomas WR. Mite allergens groups I-VII. A catalogue of enzymes. Clin Exp Allergy 1993, 23:350-3. 10.1111/j.1365-2222.1993.tb00338.x, 7687508.
3. Chang YC, Hsieh KH. The study of house dust mites in Taiwan. Ann Allergy 1989, 62:101-6.
4. Chua KY, Doyle CR, Simpson RJ, Turner KJ, Stewart GA, Thomas WR. Isolation of cDNA coding for the major mite allergen Der p II by IgE plaque immunoassay. Int Arch Allergy Appl Immunol 1990, 91:118-23. 10.1159/000235101, 2341191.
5. Nagata M, Nakagome K. Allergen immunotherapy in asthma: current status and future perspectives. Allergol Int 2010, 59:15-9. 10.2332/allergolint.09-RAI-0150, 20093852.
6. O'Hehir RE, Gardner LM, de Leon MP, Hales BJ, Biondo M, Douglass JA, Rolland JM, Sandrini A. House dust mite sublingual immunotherapy: the role for transforming growth factor-beta and functional regulatory T cells. Am J Respir Crit Care Med 2009, 180:936-47. 10.1164/rccm.200905-0686OC, 19696440.
7. Polosa R, Al-Delaimy WK, Russo C, Piccillo G, Sarva M. Greater risk of incident asthma cases in adults with allergic rhinitis and effect of allergen immunotherapy: a retrospective cohort study. Respir Res 2005, 6:153. 10.1186/1465-9921-6-153, 1351177, 16381607.
8. Niggemann B, Jacobsen L, Dreborg S, Ferdousi HA, Halken S, Host A, Koivikko A, Koller D, Norberg LA, Urbanek R, Valovirta E, Wahn U, Moller C. Five-year follow-up on the PAT study: specific immunotherapy and long-termprevention of asthma in children. Allergy 2006, 61:855-9. 10.1111/j.1398-9995.2006.01068.x, 16792584.
9. Williams AP, Krishna MT, Frew AJ. The safety of immunotherapy. Clin Exp Allergy 2004, 34:513-4. 10.1111/j.1365-2222.2004.1927.x, 15080799.
10. Novembre E, Galli E, Landi F, Caffarelli C, Pifferi M, De Marco E, Burastero SE, Calori G, Benetti L, Bonazza P, Puccinelli P, Parmiani S, Bernardini R, Vierucci A. Coseasonal sublingual immunotherapy reduces the development of asthma in children with allergic rhinoconjunctivitis. J Allergy Clin Immunol 2004, 114:851-7. 10.1016/j.jaci.2004.07.012, 15480326.
11. Valovirta E, Jacobsen L, Ljorring C, Koivikko A, Savolainen J. Clinical efficacy and safety of sublingual immunotherapy with tree pollen extract in children. Allergy 2006, 61:1177-83. 10.1111/j.1398-9995.2006.01190.x, 16942565.
12. Burks AW, Laubach S, Jones SM. Oral tolerance, food allergy, and immunotherapy: implications for future treatment. J Allergy Clin Immunol 2008, 121:1344-50. 10.1016/j.jaci.2008.02.037, 18410959.
13. Pauli G, Larsen TH, Rak S, Horak F, Pastorello E, Valenta R, Purohit A, Arvidsson M, Kavina A, Schroeder JW, Mothes N, Spitzauer S, Montagut A, Galvain S, Melac M, Andre C, Poulsen LK, Malling HJ. Efficacy of recombinant birch pollen vaccine for the treatment of birch-allergic rhinoconjunctivitis. J Allergy Clin Immunol 2008, 122:951-60. 10.1016/j.jaci.2008.09.017, 19000581.
14. Purohit A, Niederberger V, Kronqvist M, Horak F, Gronneberg R, Suck R, Weber B, Fiebig H, van Hage M, Pauli G, Valenta R, Cromwell O. Clinical effects of immunotherapy with genetically modified recombinant birch pollen Bet v 1 derivatives. Clin Exp Allergy 2008, 38:1514-25. 10.1111/j.1365-2222.2008.03042.x, 18564326.
15. Chen HL, Wang LC, Chang CH, Yen CC, Cheng WT, Wu SC, Hung CM, Kuo MF, Chen CM. Recombinant porcine lactoferrin expressed in the milk of transgenic mice protects neonatal mice from a lethal challenge with enterovirus type 71. Vaccine 2008, 26:891-8. 10.1016/j.vaccine.2007.12.013, 18207613.
16. Chen HL, Huang JY, Chu TW, Tsai TC, Hung CM, Lin CC, Liu FC, Wang LC, Chen YJ, Lin MF, Chen CM. Expression of VP1 protein in the milk of transgenic mice: a potential oral vaccine protects against enterovirus 71 infection. Vaccine 2008, 26:2882-9. 10.1016/j.vaccine.2008.03.041, 18450335.
17. Chen CM, Wang CH, Wu SC, Lin CC, Lin SH, Cheng WT. Temporal and spatial expression of biologically active human factor VIII in the milk of transgenic mice driven by mammary-specific bovine alpha-lactalbumin regulation sequences. Transgenic Res 2002, 11:257-68. 10.1023/A:1015651302674, 12113458.
18. Tung YT, Chen HL, Lai CW, Shen CJ, Lai YW, Chen CM. Curcumin reduces pulmonary tumorigenesis in vascular endothelial growth factor (VEGF)-overexpressing transgenic mice. Mol Nutri Food Res 2011, 55:1036-43.
19. Yen CC, Lin CY, Chong KY, Tsai TC, Shen CJ, Lin MF, Su CY, Chen HL, Chen CM. Lactoferrin as a natural regimen of selective decontamination of the digestive tract: recombinant porcine lactoferrin expressed in the milk of transgenic mice protects neonates from pathogen challenges in the gastrointestinal tract. J Infect Dis 2009, 199:590-8. 10.1086/596212, 19125673.
20. Chen CM, Chen HL, Hsiau THC, Hsiau AH, Shi H, Brock GJ, Wei SH, Caldwell CW, Yan PS, Huang TH. Methylation target array for rapid analysis of CpG island hypermethylation in multiple tissue genomes. Am J Pathol 2003, 163:37-45. 10.1016/S0002-9440(10)63628-0, 1868173, 12819009.
21. Chen YJ, Wu CY, Chang CC, Ma CJ, Li MC, Chen CM. Nuclear Kruppel-like factor 4 expression is associated with human skin squamous cell carcinoma progression and metastasis. Cancer Biol Ther 2008, 7:777-82. 10.4161/cbt.7.5.5768, 18376139.
22. Hamelmann E, Schwarze J, Takeda K, Oshiba A, Larsen GL, Irvin CG, Gelfand EW. Noninvasive measurement of airway responsiveness in allergic mice using barometric plethysmography. Am J Respir Crit Care Med 1997, 156:766-75. 10.1164/ajrccm.156.3.9606031, 9309991.
23. Yen CC, Lai YW, Chen HL, Lai CW, Lin CY, Chen W, Kuan YP, Hsu WH, Chen CM. Aerosolized human extracellular superoxide dismutase prevents hyperoxia-induced lung injury. PLoS One 2011, 6:e26870. 10.1371/journal.pone.0026870, 3202580, 22046389.
24. Verhasselt V, Milcent V, Cazareth J, Kanda A, Fleury S, Dombrowicz D, Glaichenhaus N, Julia V. Breast milk-mediated transfer of an antigen induces tolerance and protection from allergic asthma. Nat Med 2008, 14:170-5. 10.1038/nm1718, 18223654.
25. Hsu CH, Lin SS, Liu FL, Su WC, Yeh SD. Oral administration of a mite allergen expressed by zucchini yellow mosaic virus in cucurbit species downregulates allergen-induced airway inflammation and IgE synthesis. J Allergy Clin Immunol 2004, 113:1079-85. 10.1016/j.jaci.2004.02.047, 15208588.
26. Verhasselt V. Neonatal tolerance under breastfeeding influence. Curr Opin Immunol 2010, 22:623-30. 10.1016/j.coi.2010.08.008, 20851590.
27. Mosconi E, Rekima A, Seitz-Polski B, Kanda A, Fleury S, Tissandie E, Monteiro R, Dombrowicz DD, Julia V, Glaichenhaus N, Verhasselt V. Breast milk immune complexes are potent inducers of oral tolerance in neonates and prevent asthma development. Mucosal Immunol 2010, 3:461-74. 10.1038/mi.2010.23, 20485331.
28. Drachenberg KJ, Wheeler AW, Stuebner P, Horak F. A well-tolerated grass pollen-specific allergy vaccine containing a novel adjuvant, monophosphoryl lipid A, reduces allergic symptoms after only four preseasonal injections. Allergy 2001, 56:498-505. 10.1034/j.1398-9995.2001.056006498.x, 11421893.
29. Tulic MK, Fiset PO, Christodoulopoulos P, Vaillancourt P, Desrosiers M, Lavigne F, Eiden J, Hamid Q. Amb a 1-immunostimulatory oligodeoxynucleotide conjugate immunotherapy decreases the nasal inflammatory response. J Allergy Clin Immunol 2004, 113:235-41. 10.1016/j.jaci.2003.11.001, 14767435.
30. Creticos PS, Schroeder JT, Hamilton RG, Balcer-Whaley SL, Khattignavong AP, Lindblad R, Li H, Coffman R, Seyfert V, Eiden JJ, Broide D. Immunotherapy with a ragweed-toll-like receptor 9 agonist vaccine for allergic rhinitis. N Engl J Med 2006, 355:1445-55. 10.1056/NEJMoa052916, 17021320.
31. Houdebine LM. Transgenic animal bioreactors. Transgenic Res 2000, 9:305-20. 10.1023/A:1008934912555, 11131009.
32. Houdebine LM. Production of pharmaceutical proteins by transgenic animals. Comp Immunol Microbiol Infect Dis 2009, 32:107-21. 10.1016/j.cimid.2007.11.005, 18243312.
33. Zinovieva N, Lassnig C, Schams D, Besenfelder U, Wolf E, Muller S, Frenyo L, Seregi J, Muller M, Brem G. Stable production of human insulin-like growth factor 1 (IGF-1) in the milk of hemi- and homozygous transgenic rabbits over several generations. Transgenic Res 1998, 7:437-47. 10.1023/A:1008831028620, 10341452.
34. Devinoy E, Thepot D, Stinnakre MG, Fontaine ML, Grabowski H, Puissant C, Pavirani A, Houdebine LM. High level production of human growth hormone in the milk of transgenic mice: the upstream region of the rabbit whey acidic protein (WAP) gene targets transgene expression to the mammary gland. Transgenic Res 1994, 3:79-89. 10.1007/BF01974085, 8193641.
35. Ebert KM, Selgrath JP, DiTullio P, Denman J, Smith TE, Memon MA, Schindler JE, Monastersky GM, Vitale JA, Gordon K. Transgenic production of a variant of human tissue-type plasminogen activator in goat milk: generation of transgenic goats and analysis of expression. Biotechnol NY 1991, 9:835-838.
36. Kuroiwa Y, Kasinathan P, Choi YJ, Naeem R, Tomizuka K, Sullivan EJ, Knott JG, Duteau A, Goldsby RA, Osborne BA, Ishida I, Robl JM. Cloned transchromosomic calves producing human immunoglobulin. Nat Biotechnol 2002, 20:889-94. 10.1038/nbt727, 12172556.
37. van Berkel PH, Welling MM, Geerts M, van Veen HA, Ravensbergen B, Salaheddine M, Pauwels EK, Pieper F, Nuijens JH, Nibbering PH. Large scale production of recombinant human lactoferrin in the milk of transgenic cows. Nat Biotechnol 2002, 20:484-7. 10.1038/nbt0502-484, 11981562.
38. Adiguzel C, Iqbal O, Demir M, Fareed J. European community and US-FDA approval of recombinant human antithrombin produced in genetically altered goats. Clin Appl Thromb Hemost 2009, 15:645-51. 10.1177/1076029609339748, 19850586.